Cargando…
The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis
Cardiac fibrosis often has adverse cardiovascular effects, including heart failure, sudden death, and malignant arrhythmias. However, there is no targeted therapy for cardiac fibrosis. Inflammation is known to play a crucial role in the disorder, and the NLR pyrin domain-containing-3 (NLRP3) inflamm...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273832/ https://www.ncbi.nlm.nih.gov/pubmed/35836721 http://dx.doi.org/10.2147/JIR.S370483 |